Global Preclinical Contract Research Organizations Market to Reach $6.9 Billion by 2027

Abstract: - Global Preclinical Contract Research Organizations Market to Reach $6. 9 Billion by 2027. - Amid the COVID-19 crisis, the global market for Preclinical Contract Research Organizations estimated at US$4.

New York, July 07, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Preclinical Contract Research Organizations Industry" - https://www.reportlinker.com/p06032639/?utm_source=GNW
3 Billion in the year 2020, is projected to reach a revised size of US$6.9 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Toxicology Testing, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bioanalysis & DMPK Studies segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 6.4% CAGR
- The Preclinical Contract Research Organizations market in the U.S. is estimated at US$1.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.
- Other Services Segment to Record 6.3% CAGR
- In the global Other Services segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$524.8 Million in the year 2020 will reach a projected size of US$807.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$792 Million by the year 2027.

- Select Competitors (Total 35 Featured) -

• Envigo Corporation

• Eurofins Scientific

• ICON Plc

• Laboratory Corporation of America, Inc.

• Medpace, Inc.

• MPI research

• PARAXEL International Corporation

• Pharmaceutical Product Development (PPD), LLC

• PRA Health Sciences, Inc.

• Wuxi AppTec

Read the full report: https://www.reportlinker.com/p06032639/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Preclinical
Contract Research Organizations by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Preclinical Contract
Research Organizations by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Preclinical Contract
Research Organizations by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2012, 2020 &
2027

Table 4: World Current & Future Analysis for Toxicology Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Toxicology Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Toxicology Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Bioanalysis & DMPK
Studies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Bioanalysis & DMPK Studies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Bioanalysis & DMPK
Studies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Other Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Other Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Other Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Biopharma
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 14: World Historic Review for Biopharma Companies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Biopharma Companies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Government &
Academic Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Government & Academic
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 18: World 15-Year Perspective for Government & Academic
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Medical Device
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: World Historic Review for Medical Device Companies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Medical Device
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 22: USA Current & Future Analysis for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 23: USA Historic Review for Preclinical Contract Research
Organizations by Service - Toxicology Testing, Bioanalysis &
DMPK Studies and Other Services Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: USA 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 25: USA Current & Future Analysis for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Preclinical Contract Research
Organizations by End-Use - Biopharma Companies, Government &
Academic Institutes and Medical Device Companies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

CANADA
Table 28: Canada Current & Future Analysis for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 29: Canada Historic Review for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: Canada 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 31: Canada Current & Future Analysis for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

JAPAN
Table 34: Japan Current & Future Analysis for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 35: Japan Historic Review for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 36: Japan 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 37: Japan Current & Future Analysis for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

CHINA
Table 40: China Current & Future Analysis for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 41: China Historic Review for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 42: China 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 43: China Current & Future Analysis for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

EUROPE
Table 46: Europe Current & Future Analysis for Preclinical
Contract Research Organizations by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 47: Europe Historic Review for Preclinical Contract
Research Organizations by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 48: Europe 15-Year Perspective for Preclinical Contract
Research Organizations by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 49: Europe Current & Future Analysis for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 51: Europe 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

FRANCE
Table 55: France Current & Future Analysis for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: France Historic Review for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 57: France 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 58: France Current & Future Analysis for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

GERMANY
Table 61: Germany Current & Future Analysis for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: Germany Historic Review for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 63: Germany 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 64: Germany Current & Future Analysis for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 65: Germany Historic Review for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

ITALY
Table 67: Italy Current & Future Analysis for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: Italy Historic Review for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 69: Italy 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 70: Italy Current & Future Analysis for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 71: Italy Historic Review for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

UNITED KINGDOM
Table 73: UK Current & Future Analysis for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 74: UK Historic Review for Preclinical Contract Research
Organizations by Service - Toxicology Testing, Bioanalysis &
DMPK Studies and Other Services Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 75: UK 15-Year Perspective for Preclinical Contract
Research Organizations by Service - Percentage Breakdown of
Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies
and Other Services for the Years 2012, 2020 & 2027

Table 76: UK Current & Future Analysis for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 77: UK Historic Review for Preclinical Contract Research
Organizations by End-Use - Biopharma Companies, Government &
Academic Institutes and Medical Device Companies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Preclinical Contract
Research Organizations by End-Use - Percentage Breakdown of
Value Sales for Biopharma Companies, Government & Academic
Institutes and Medical Device Companies for the Years 2012,
2020 & 2027

REST OF EUROPE
Table 79: Rest of Europe Current & Future Analysis for
Preclinical Contract Research Organizations by Service -
Toxicology Testing, Bioanalysis & DMPK Studies and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 80: Rest of Europe Historic Review for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 81: Rest of Europe 15-Year Perspective for Preclinical
Contract Research Organizations by Service - Percentage
Breakdown of Value Sales for Toxicology Testing, Bioanalysis &
DMPK Studies and Other Services for the Years 2012, 2020 & 2027

Table 82: Rest of Europe Current & Future Analysis for
Preclinical Contract Research Organizations by End-Use -
Biopharma Companies, Government & Academic Institutes and
Medical Device Companies - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 83: Rest of Europe Historic Review for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 84: Rest of Europe 15-Year Perspective for Preclinical
Contract Research Organizations by End-Use - Percentage
Breakdown of Value Sales for Biopharma Companies, Government &
Academic Institutes and Medical Device Companies for the Years
2012, 2020 & 2027

ASIA-PACIFIC
Table 85: Asia-Pacific Current & Future Analysis for
Preclinical Contract Research Organizations by Service -
Toxicology Testing, Bioanalysis & DMPK Studies and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 86: Asia-Pacific Historic Review for Preclinical Contract
Research Organizations by Service - Toxicology Testing,
Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: Asia-Pacific 15-Year Perspective for Preclinical
Contract Research Organizations by Service - Percentage
Breakdown of Value Sales for Toxicology Testing, Bioanalysis &
DMPK Studies and Other Services for the Years 2012, 2020 & 2027

Table 88: Asia-Pacific Current & Future Analysis for
Preclinical Contract Research Organizations by End-Use -
Biopharma Companies, Government & Academic Institutes and
Medical Device Companies - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 89: Asia-Pacific Historic Review for Preclinical Contract
Research Organizations by End-Use - Biopharma Companies,
Government & Academic Institutes and Medical Device Companies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 90: Asia-Pacific 15-Year Perspective for Preclinical
Contract Research Organizations by End-Use - Percentage
Breakdown of Value Sales for Biopharma Companies, Government &
Academic Institutes and Medical Device Companies for the Years
2012, 2020 & 2027

REST OF WORLD
Table 91: Rest of World Current & Future Analysis for
Preclinical Contract Research Organizations by Service -
Toxicology Testing, Bioanalysis & DMPK Studies and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 92: Rest of World Historic Review for Preclinical
Contract Research Organizations by Service - Toxicology
Testing, Bioanalysis & DMPK Studies and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 93: Rest of World 15-Year Perspective for Preclinical
Contract Research Organizations by Service - Percentage
Breakdown of Value Sales for Toxicology Testing, Bioanalysis &
DMPK Studies and Other Services for the Years 2012, 2020 & 2027

Table 94: Rest of World Current & Future Analysis for
Preclinical Contract Research Organizations by End-Use -
Biopharma Companies, Government & Academic Institutes and
Medical Device Companies - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 95: Rest of World Historic Review for Preclinical
Contract Research Organizations by End-Use - Biopharma
Companies, Government & Academic Institutes and Medical Device
Companies Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 96: Rest of World 15-Year Perspective for Preclinical
Contract Research Organizations by End-Use - Percentage
Breakdown of Value Sales for Biopharma Companies, Government &
Academic Institutes and Medical Device Companies for the Years
2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 35
Read the full report: https://www.reportlinker.com/p06032639/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001